Cook’s Zilver Vena™ Venous Stent Expands Into Canada

Cook Medical made the Zilver Vena™ Venous Self-Expanding Stent available to physicians across Canada at last week’s 2012 Annual Meeting of the Canadian Society for Vascular Surgery. Designed to restore blood flow in obstructed iliofemoral veins, Cook says the purpose-designed stent provides physicians with a tool designed specifically for the task.

Cook Medical Opens New $19M U.S. Medical Device Manufacturing Plant

This is what targeted investment in a community looks like, as Cook Medical and its parent Cook Group adds a new manufacturing facility to Canton Illinois, having already built one two years ago… and a boutique hotel! Little wonder the company feels it has the moral high ground as it fights the Government’s new medtech tax plans.

- in: Categories ,

Cook Medical’s Ongoing Zilver® PTX Trial Data Show Higher Freedom From Target Lesion Revascularisation At 3 Years Than Angioplasty and Bare Metal Stents

Cook Medical’s Zilver® PTX paclitaxel-eluting peripheral vascular stent demonstrated 83.0 percent freedom from Target Lesion Revascularisation at 36 months in the PTX group, compared to 70.2 percent for patients treated with optimal percutaneous transluminal angioplasty and bare metal stents in the 479 patient study.

New Study Will Investigate Potential Of Retrograde Endovascular Approach To Occluded Lower Limb Arteries

A new technique involving retrograde endovascular approach to occluded peripheral arteries shows promise, but hasn’t yet been formally studied. Cook Medical is supporting a multicentre effort to build an evidence base for what could be a promising solution to the major healthcare problems resulting from peripheral artery disease.